Cargando…

WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation

BACKGROUND: Congenital heart disease (CHD) is the most common birth defect and has high heritability. Although some susceptibility genes have been identified, the genetic basis underlying the majority of CHD cases is still undefined. METHODS: A total of 1320 unrelated CHD patients were enrolled in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Lili, Ma, Jing, Wu, Feizhen, Ma, Xiaojing, Qian, Maoxiang, Sheng, Wei, Yan, Tizhen, Tang, Ning, Jiang, Xin, Zhang, Bowen, Xiao, Deyong, Qian, Yanyan, Zhang, Jin, Jiang, Nan, Zhou, Wenhao, Chen, Weicheng, Ma, Duan, Huang, Guoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270576/
https://www.ncbi.nlm.nih.gov/pubmed/35808830
http://dx.doi.org/10.1002/ctm2.941
_version_ 1784744494233550848
author Hao, Lili
Ma, Jing
Wu, Feizhen
Ma, Xiaojing
Qian, Maoxiang
Sheng, Wei
Yan, Tizhen
Tang, Ning
Jiang, Xin
Zhang, Bowen
Xiao, Deyong
Qian, Yanyan
Zhang, Jin
Jiang, Nan
Zhou, Wenhao
Chen, Weicheng
Ma, Duan
Huang, Guoying
author_facet Hao, Lili
Ma, Jing
Wu, Feizhen
Ma, Xiaojing
Qian, Maoxiang
Sheng, Wei
Yan, Tizhen
Tang, Ning
Jiang, Xin
Zhang, Bowen
Xiao, Deyong
Qian, Yanyan
Zhang, Jin
Jiang, Nan
Zhou, Wenhao
Chen, Weicheng
Ma, Duan
Huang, Guoying
author_sort Hao, Lili
collection PubMed
description BACKGROUND: Congenital heart disease (CHD) is the most common birth defect and has high heritability. Although some susceptibility genes have been identified, the genetic basis underlying the majority of CHD cases is still undefined. METHODS: A total of 1320 unrelated CHD patients were enrolled in our study. Exome‐wide association analysis between 37 tetralogy of Fallot (TOF) patients and 208 Han Chinese controls from the 1000 Genomes Project was performed to identify the novel candidate gene WD repeat‐containing protein 62 (WDR62). WDR62 variants were searched in another expanded set of 200 TOF patients by Sanger sequencing. Rescue experiments in zebrafish were conducted to observe the effects of WDR62 variants. The roles of WDR62 in heart development were examined in mouse models with Wdr62 deficiency. WDR62 variants were investigated in an additional 1083 CHD patients with similar heart phenotypes to knockout mice by multiplex PCR‐targeting sequencing. The cellular phenotypes of WDR62 deficiency and variants were tested in cardiomyocytes, and the molecular mechanisms were preliminarily explored by RNA‐seq and co‐immunoprecipitation. RESULTS: Seven WDR62 coding variants were identified in the 237 TOF patients and all were indicated to be loss of function variants. A total of 25 coding and 22 non‐coding WDR62 variants were identified in 80 (6%) of the 1320 CHD cases sequenced, with a higher proportion of WDR62 variation (8%) found in the ventricular septal defect (VSD) cohort. WDR62 deficiency resulted in a series of heart defects affecting the outflow tract and right ventricle in mouse models, including VSD as the major abnormality. Cell cycle arrest and an increased number of cells with multipolar spindles that inhibited proliferation were observed in cardiomyocytes with variants or knockdown of WDR62. WDR62 deficiency weakened the association between WDR62 and the cell cycle‐regulated kinase AURKA on spindle poles, reduced the phosphorylation of AURKA, and decreased expression of target genes related to cell cycle and spindle assembly shared by WDR62 and AURKA. CONCLUSIONS: WDR62 was identified as a novel susceptibility gene for CHD with high variant frequency. WDR62 was shown to participate in the cardiac development by affecting spindle assembly and cell cycle pathway in cardiomyocytes.
format Online
Article
Text
id pubmed-9270576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92705762022-07-14 WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation Hao, Lili Ma, Jing Wu, Feizhen Ma, Xiaojing Qian, Maoxiang Sheng, Wei Yan, Tizhen Tang, Ning Jiang, Xin Zhang, Bowen Xiao, Deyong Qian, Yanyan Zhang, Jin Jiang, Nan Zhou, Wenhao Chen, Weicheng Ma, Duan Huang, Guoying Clin Transl Med Research Articles BACKGROUND: Congenital heart disease (CHD) is the most common birth defect and has high heritability. Although some susceptibility genes have been identified, the genetic basis underlying the majority of CHD cases is still undefined. METHODS: A total of 1320 unrelated CHD patients were enrolled in our study. Exome‐wide association analysis between 37 tetralogy of Fallot (TOF) patients and 208 Han Chinese controls from the 1000 Genomes Project was performed to identify the novel candidate gene WD repeat‐containing protein 62 (WDR62). WDR62 variants were searched in another expanded set of 200 TOF patients by Sanger sequencing. Rescue experiments in zebrafish were conducted to observe the effects of WDR62 variants. The roles of WDR62 in heart development were examined in mouse models with Wdr62 deficiency. WDR62 variants were investigated in an additional 1083 CHD patients with similar heart phenotypes to knockout mice by multiplex PCR‐targeting sequencing. The cellular phenotypes of WDR62 deficiency and variants were tested in cardiomyocytes, and the molecular mechanisms were preliminarily explored by RNA‐seq and co‐immunoprecipitation. RESULTS: Seven WDR62 coding variants were identified in the 237 TOF patients and all were indicated to be loss of function variants. A total of 25 coding and 22 non‐coding WDR62 variants were identified in 80 (6%) of the 1320 CHD cases sequenced, with a higher proportion of WDR62 variation (8%) found in the ventricular septal defect (VSD) cohort. WDR62 deficiency resulted in a series of heart defects affecting the outflow tract and right ventricle in mouse models, including VSD as the major abnormality. Cell cycle arrest and an increased number of cells with multipolar spindles that inhibited proliferation were observed in cardiomyocytes with variants or knockdown of WDR62. WDR62 deficiency weakened the association between WDR62 and the cell cycle‐regulated kinase AURKA on spindle poles, reduced the phosphorylation of AURKA, and decreased expression of target genes related to cell cycle and spindle assembly shared by WDR62 and AURKA. CONCLUSIONS: WDR62 was identified as a novel susceptibility gene for CHD with high variant frequency. WDR62 was shown to participate in the cardiac development by affecting spindle assembly and cell cycle pathway in cardiomyocytes. John Wiley and Sons Inc. 2022-07-08 /pmc/articles/PMC9270576/ /pubmed/35808830 http://dx.doi.org/10.1002/ctm2.941 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Hao, Lili
Ma, Jing
Wu, Feizhen
Ma, Xiaojing
Qian, Maoxiang
Sheng, Wei
Yan, Tizhen
Tang, Ning
Jiang, Xin
Zhang, Bowen
Xiao, Deyong
Qian, Yanyan
Zhang, Jin
Jiang, Nan
Zhou, Wenhao
Chen, Weicheng
Ma, Duan
Huang, Guoying
WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title_full WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title_fullStr WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title_full_unstemmed WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title_short WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
title_sort wdr62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270576/
https://www.ncbi.nlm.nih.gov/pubmed/35808830
http://dx.doi.org/10.1002/ctm2.941
work_keys_str_mv AT haolili wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT majing wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT wufeizhen wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT maxiaojing wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT qianmaoxiang wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT shengwei wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT yantizhen wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT tangning wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT jiangxin wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT zhangbowen wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT xiaodeyong wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT qianyanyan wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT zhangjin wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT jiangnan wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT zhouwenhao wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT chenweicheng wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT maduan wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation
AT huangguoying wdr62variantscontributetocongenitalheartdiseasebyinhibitingcardiomyocyteproliferation